Literature DB >> 12099543

Adenylyl cyclase activity mediated by beta-adrenoceptors in immortalized human trabecular meshwork and non-pigmented ciliary epithelial cells.

Julie Y Crider1, Najam A Sharif.   

Abstract

Non-pigmented ciliary epithelial (NPE) and trabecular meshwork (TM) cells are important in maintaining normal aqueous humor dynamics through the inflow and outflow routes, respectively. The current studies were undertaken to evaluate the ability of several beta-adrenergic receptor agonists to stimulate various antagonists to inhibit cAMP production in cultured immortalized human TM and NPE cells using an automated enzyme immunoassay. Isoproterenol was the most potent agonist in both the NPE and TM cells. The rank order of potency of agonists in NPE and TM cells, respectively, was: isoproterenol [EC50 = 37 and 66 nM] > epinephrine [EC50 = 112 and 526 nM] > albuterol [EC50 = 426 and 785 nM] > norepinephrine [EC50 = 3 and > 10 microM] > phenylephrine [EC50 > 10 microM for both] = dopamine [EC50 > 10 microM for both](n = 3-19). The isoproterenol-induced cAMP production was inhibited by various antagonists with the following rank order of potency in NPE and TM cells, respectively: propranolol [Ki = 0.2 and 0.3 nM] = ICI-118551 [Ki = 0.5 and 0.4 nM] > levobunolol [Ki = 1.1 and 2.1 nM] > levobetaxolol [Ki = 13 and 14 nM] = racemic betaxolol [Ki = 43 and 19 nM] > dextrobetaxolol [Ki = 2,705 and 1,980 nM] > atenolol [Ki > 4,000 nM for both] (n = 3-7). These detailed pharmacological studies using a variety of agonists and antagonists further supported the presence of beta2-adrenergic receptors in immortalized human NPE and TM cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12099543     DOI: 10.1089/108076802760116142

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  14 in total

1.  GPR158 in the Visual System: Homeostatic Role in Regulation of Intraocular Pressure.

Authors:  Tatsuo Itakura; Andrew Webster; Shravan K Chintala; Yuchen Wang; Jose M Gonzalez; J C Tan; Janice A Vranka; Ted Acott; Cheryl Mae Craft; Maria E Sibug Saber; Shinwu Jeong; W Daniel Stamer; Kirill A Martemyanov; M Elizabeth Fini
Journal:  J Ocul Pharmacol Ther       Date:  2019-03-18       Impact factor: 2.671

2.  Discovery to Launch of Anti-allergy (Emadine; Patanol/Pataday/Pazeo) and Anti-glaucoma (Travatan; Simbrinza) Ocular Drugs, and Generation of Novel Pharmacological Tools Such as AL-8810.

Authors:  Najam A Sharif
Journal:  ACS Pharmacol Transl Sci       Date:  2020-11-05

3.  Levobetaxolol hydrochloride: a review of its pharmacology and use in the treatment of chronic open-angle glaucoma and ocular hypertension.

Authors:  Luciano Quaranta; Raffaele Turano; Teodoro Pizzolante
Journal:  Clin Ophthalmol       Date:  2007-06

4.  A3 adenosine and CB1 receptors activate a PKC-sensitive Cl- current in human nonpigmented ciliary epithelial cells via a G beta gamma-coupled MAPK signaling pathway.

Authors:  Chanjuan Shi; Anna Szczesniak; Lucy Mao; Christine Jollimore; Miguel Coca-Prados; Orlando Hung; Melanie E M Kelly
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

5.  Beta 2-adrenergic receptor polymorphism and susceptibility to primary congenital and primary open angle glaucoma.

Authors:  Kivanc Güngör; Mehtap Ozkur; Ingolf Cascorbi; Jürgen Brockmöller; Necdet Bekir; Ivar Roots; A Sükrü Aynacioglu
Journal:  Eur J Clin Pharmacol       Date:  2003-09-12       Impact factor: 2.953

6.  Agonistic β2-Adrenergic Receptor Autoantibodies Characterize the Aqueous Humor of Patients With Primary and Secondary Open-Angle Glaucoma.

Authors:  Bettina Hohberger; Max Wörn; Robert Lämmer; Aparna Mahajan; Christian Mardin; Ursula Schötzer-Schrehardt; Rudolph Kunze; Martin Herrmann; Gerd Wallukat
Journal:  Front Immunol       Date:  2021-05-05       Impact factor: 7.561

7.  Agonistic autoantibodies against ß2-adrenergic receptor influence retinal microcirculation in glaucoma suspects and patients.

Authors:  Bettina Hohberger; Sami Hosari; Gerd Wallukat; Rudolf Kunze; Johann Krebs; Meike Müller; Till Hennig; Robert Lämmer; Folkert Horn; Luis E Muñoz; Martin Herrmann; Christian Mardin
Journal:  PLoS One       Date:  2021-05-07       Impact factor: 3.240

8.  Pharmacological properties and discriminative stimulus effects of a novel and selective 5-HT2 receptor agonist AL-38022A [(S)-2-(8,9-dihydro-7H-pyrano[2,3-g]indazol-1-yl)-1-methylethylamine].

Authors:  Jesse A May; Najam A Sharif; Hwang-Hsing Chen; John C Liao; Curtis R Kelly; Richard A Glennon; Richard Young; Jun-Xu Li; Kenner C Rice; Charles P France
Journal:  Pharmacol Biochem Behav       Date:  2008-07-30       Impact factor: 3.697

9.  Inhibition by brimonidine of forskolin-induced nitric oxide synthase expression in human ciliary bodies in vitro.

Authors:  Renyi Wu; Jinfu Yin; Ke Yao; Ivan Haefliger
Journal:  Mol Vis       Date:  2007-04-02       Impact factor: 2.367

10.  Agonistic Autoantibodies to the β2-Adrenergic Receptor Involved in the Pathogenesis of Open-Angle Glaucoma.

Authors:  Anselm Jünemann; Bettina Hohberger; Jürgen Rech; Ahmed Sheriff; Qin Fu; Ursula Schlötzer-Schrehardt; Reinhard Edmund Voll; Sabine Bartel; Hubert Kalbacher; Johan Hoebeke; Robert Rejdak; Folkert Horn; Gerd Wallukat; Rudolf Kunze; Martin Herrmann
Journal:  Front Immunol       Date:  2018-02-12       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.